EcoDrugPlus

Ensembl ID : ENSPNYG00000020789
Gene Symbol: -
Cross references: -
5 Possible Orthologues:

Ensembl ID : ENSPNYG00000001972
Gene Symbol: -
Cross references: -
115 Possible Orthologues:

Ensembl ID : ENSPNYG00000007883
Gene Symbol: -
Cross references: -
213 Possible Orthologues:

Ensembl ID : ENSPNYG00000022361
Gene Symbol: -
Cross references: -
244 Possible Orthologues:

Ensembl ID : ENSPNYG00000017896
Gene Symbol: -
Cross references: -
233 Possible Orthologues:

Ensembl ID : ENSPNYG00000001777
Gene Symbol: -
Cross references: -
214 Possible Orthologues:

Ensembl ID : ENSPNYG00000017734
Gene Symbol: -
Cross references: -
211 Possible Orthologues:

Ensembl ID : ENSPNYG00000007157
Gene Symbol: -
Cross references: -
226 Possible Orthologues:

Ensembl ID : ENSPNYG00000017782
Gene Symbol: -
Cross references: -
153 Possible Orthologues:

Ensembl ID : ENSPNYG00000002322
Gene Symbol: -
Cross references: -
247 Possible Orthologues:

Ensembl ID : ENSPNYG00000011946
Gene Symbol: -
Cross references: -
153 Possible Orthologues:

Ensembl ID : ENSPNYG00000004407
Gene Symbol: -
Cross references: -
116 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).